Nonspecificity of p30/32MIC2 immunolocalization with the 013 monoclonal antibody in the diagnosis of Ewing's sarcoma: Application of an algorithmic immimohistochemical analysis

Applied Immunohistochemistry and Molecular Morphology

Volumn 5, Issue 2, 1997, Pages 94-103

  Hess, Eva ^a   Cohen, Cynthia ^b   DeRose, Patricia B ^b   Yost, Barbara A ^a   Costa, Michael J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lymphoma; Primitive peripheral neuroectodermal tumor; Small round blue cell tumors

Indexed keywords

ACTIN; CD45 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; DESMIN; MONOCLONAL ANTIBODY; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; EWING SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

EID: 0030926665     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199706000-00004     Document Type: Article

References (26)

1. Smith MJ, Goodfellow PJ, Goodfellow PN. The genomic organization of the human pseudoautosomal gene MIC2 and the detection of a related locus. Hum Mol Genet 1993;2:417-22.
2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MCI2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886-93.
3. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993;17:1-13.
4. Dehner LP. Neuroepithelioma (primitive neuroectodermal tumor) and Ewing's sarcoma: at least a partial consensus. Arch Pathol Lab Med 1994;118:606-7.
5. Fellinger EJ, Garin-Chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;39:317-25.
6. Fellinger EJ, Garin-Chesa P, Glasser DB, Huvos AG, Rettig WJ. Comparison of cell surface antigen HBA71 (p30/31 MIC2), neuron-specific enolase, and vimentin the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 1992;16:746-55.
7. Garin-Chesa P, Swanson PE, Rettig WJ, Huvos AG. Immunohistochemical analysis of small round cell tumors for expression of the MIC2 gene product (HBA71 antigen) [Abstract]. Mod Pathol 1993;6A.
8. Hicks J, Murray J, Dreyer Z, et al. Expression of proliferation-associated markers and glycoprotein P30/32 MIC2 in Ewing's sarcoma: a clinicopathologic study [Abstract]. Am J Clin Pathol 1995;104:352.
9. Johnson JE, Olson SJ Letter: MAb O13. Am J Surg Pathol 1995;19:851-2.
10. Kovar J, Dworzak M, Strehl S, et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 1990;5: 1067-70.
11. Navarro S, Casvazzana AO, Llombart-Bosch A, Triche TJ. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma: an immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. Arch Pathol 1994;11:608-15.
12. Pappo AS, Douglass EC, Meyer WH, Marina N, Parham DM. Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol 1993;24:880-5.
13. Perlman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma-Routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum Pathol 1994;25:304-7.
14. Perlman EJ, Lamadue JA, Hawkins AL, Cohen K, Colombani P, Griffin CA. Primary cutaneous neuroendocrine tumors: diagnostic use of cytogenetic and MIC2 analysis. Cancer Genet Cytogenet 1995;82:30-4.
15. Ramani P, Rampling D, Link M. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity. Histopathol 1993;23: 557-61.
16. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994; 25:396-9.
17. MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol 1996;27:408-16.
18. Shi LR, Eichelbauer D, Borchard F, Jurgens J, Gobel U, Schneider EM. Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells. Cancer Immunol Immunother 1994;38:208-13.
19. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody 013: antibody that recognizes glycoprotein p30/ 32 MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18: 486-94.
20. Chan JKC, Tsang WYW, Seneviratne S, Pau MY. The MIC2 antibody 013; practical application for the study of thymic epithelial tumors. Am J Surg Pathol 1995;19:1115-23.
21. Fellinger EJ, Garin-Chesa P, Su SL, DeAngeleis P, Lane JM, Rettig WJ. Biochemical and genetic characterization of the HBA-71 Ewing's sarcoma cell surface antigen. Cancer Res 1991;51:336-40.
22. Brigati DJ, Budgeon LR, Unger ER, et al. Immunohistochemistry is automated: development of a robotic work station based upon the capillary action principle. J Histotechnol 1988;11:165-83.
23. Devaney K, Abbondanzo SL, Shekitka KM, Wolov RB, Sweet DE. MIC2 detection in tumors of bone and adjacent soft tissues. Clin Orthop 1995;310:176-87.
24. Vartanian RK, Weidner N. Expression of monoclonal antibody 013 (marker for the MIC2 gene product) in lymphoblastic and non-lymphoblastic non-Hodgkin's lymphomas and Hodgkin's disease with and without microwave antigen retrieval [Abstract]. Am J Clin Pathol 104:350A.
25. Dworzak MM, Fritsch G, Buchinger P, et al. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994;83:415-25.
26. Lamadue JA, Askin FB, Perlman EJ. MIC2 analysis of small cell carcinoma. Am J Clin Pathol 1994;102:692-94.